Abstract
dc:description.abstractCutaneous squamous cell carcinoma (cSCC) is the most common type of potentially lethal cancer. cSCC has a good prognosis when caught early, yet 2-5% metastasise, where they are as fatal as any other metastatic cancer. Due to the high prevalence and relatively low metastasis rate, cSCC are often omitted from major cancer registries. The subsequent lack of research into this cancer type has meant that the molecular mechanisms that drive disease progression from pre-malignant actinic keratosis (AK) to malignant cSCC and their associated potential therapeutic vulnerabilities remain to be defined. To investigate these processes, we performed transcriptomic profiling of 113 patient samples including normal sun exposed skin (n=29), AK (n=14), primary cSCC (n=66) and metastases (n=4). Using gene expression signature analysis, we revealed that cSCC disease progression can be represented as a continuum from a differentiated to a progenitor like state (DP signature). Dividing samples into quartiles based on DP signature score indicated that samples in the most progenitor like state (quartile 1) are associated with increased tumour size, depth of invasion and pathologist defined poor differentiation status. To identify genes that may drive disease progression we employed differential gene expression analysis to identify genes upregulated along disease progression, in poorly differentiated tumours, and in DP quartile 1. We further filtered candidate drivers based on expression levels in a panel of patient derived cSCC cell lines (PDCLs) and investigated the potential tumour cell autonomous role of 175 genes in a high-content siRNA pool knockdown screen. 64 genes were selected for siRNA deconvolution analysis and further high-content screening assessing cell proliferation, clustering, and morphology. These studies identified 9 candidate genes as positive regulators of cSCC cell proliferation, which we are investigating further. Whole genome sequencing data from primary and metastatic samples from three patients were analysed as an alternative approach to investigate metastatic cSCC. Loss of TGFR2 and activation of PI3 Kinase signalling was associated with metastasis and was collaboratively functionally validated using genetically engineered mouse models of cSCC. To further investigate the biological basis of metastasis we transcriptionally profiled perilesional normal tissue, primary cSCC tumour tissue and matched metastases from 224 immunocompetent patients (140 non-metastasising and 84 metastasising). Bioinformatic analyses of these transcriptomes revealed pathways, processes and genes that may be important in driving metastasis.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Treanor-Taylor, Mairi
- Advisors dc:contributor.advisor
-
- Gourley, Charlie
- Bailey, Peter
- Inman, Gareth
Subjects
dc:subject × 5Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/4551